Gilead has chosen a partner for lenacapavir in the race to develop new low-frequency treatments for HIV. | Gilead has chosen ...

Kenya's health ministry, through NASCOP, NSDCC, KRCS, county governments, partners and communities, is committed to ending ...

Q3 2025 Earnings Call October 30, 2025 4:30 PM EDTCompany ParticipantsJacquie Ross - Senior Vice President of Treasury ...

The plan underscores Kenya’s progressive approach to combination HIV prevention, offering a range of proven and emerging options including condoms, the dapivirine ring, long-acting injectable ...

Q3 2025 Earnings Call Transcript October 29, 2025 GSK plc beats earnings expectations. Reported EPS is $1.48, expectations ...